Health Conditions A-Z Infectious Diseases Hepatitis C How Is Hepatitis C Diagnosed? By Nsisong Asanga Nsisong Asanga Nsisong Asanga, Writer's Website Nsisong Asanga is a public health physician and field epidemiologist with several years of clinical and field experience. health's editorial guidelines Published on February 6, 2023 Medically reviewed by Anju Goel, MD, MPH Medically reviewed by Anju Goel, MD, MPH Anju Goel, MD, MPH, is a public health consultant and physician with more than 10 years of experience in the California public health system. learn more Share this page on Facebook Share this page on Twitter Share this page on Pinterest Email this page Hepatitis C is an inflammatory liver condition caused by the hepatitis C virus (HCV). About 3% of people in the world have this virus. Roughly 2.4 million people live with hepatitis C in the United States. Hepatitis C is usually transmitted through contact with infected blood and blood products. This may include needle sharing, such as with drug injections, or from tattooing. While less common, it can also spread through unprotected sex, from a birthing parent with HCV to their baby while giving birth, and medical procedures with cross-contamination. Your healthcare provider, such as a primary care doctor, can diagnose hepatitis C. After that, they may ask you to see a specialist, such as a hepatologist (a doctor who specializes in liver care), a gastroenterologist (a doctor specializing in digestive diseases), or an infectious disease expert. Zay Nyi Nyi / Getty Images Getting a Diagnosis Your doctors will need to take your medical history, perform a physical exam, and request diagnostic tests to diagnose hepatitis C. Medical History A diagnosis usually begins with reviewing your medical history. Your healthcare provider will ask if you are experiencing any possible symptoms of hepatitis C, such as: Fatigue Malaise, a feeling of general discomfort Weight loss Bleeding easily Bruising easily Itchy skin Jaundice, or yellowing of the eyes and skin Dark-colored urine Very light-colored poop Pain in your abdomen Nausea and vomiting Joint pain Swollen arms and legs Many people with hepatitis C don't show any symptoms. Because of this, the U.S. Preventive Services Task Force recommends HCV screening for everyone aged 18-79 years, even if you don’t have any signs of liver disease. Your healthcare provider will also want to know if you have a high risk for the condition. They may ask if you: Had any blood transfusions, shared injections, or medical procedures like dialysis or organ transplantsShare personal items like razors, nail cutters, and clippersWork in a place where you are exposed to used needles and bloodWere born to a birthing parent with hepatitis CUse injected drugs or have used them in the past Have hemophilia, a condition that causes lack of blood clottingHave tattoos or piercings Physical Examination Along with asking about your history of possible symptoms, your healthcare provider may also examine you for signs of hepatitis C. Some things they’ll examine are your: Skin for changes in color, as well as spidery blood vessel patterns (called spider angioma)Arms and feet for signs of swelling Abdomen for signs of tenderness, swelling, and enlarged organs Hepatitis C Symptoms Blood Tests After the physical exam, your doctor may request some tests that can identify hepatitis C in your blood. Each test will require a blood sample that is then examined in a lab. Some of these tests are: Hepatitis C Antibody Test: This screening test detects HCV antibodies in your blood, which are specific proteins in your immune system. A positive antibody test means you have been exposed to HCV in the past: this could mean you either have a current infection or your body may have cleared the virus. Some people with HCV can clear the virus—or recover from it—either spontaneously without treatment or after taking treatments for HCV. If your hepatitis C antibody test is positive, you’ll need a confirmatory test like the hepatitis C RNA test, which can determine if you currently have hepatitis C. Hepatitis C RNA Test: This confirmatory test detects the RNA—a type of genetic material—from the hepatitis C virus. The hepatitis C RNA test can detect an ongoing hepatitis C infection and help estimate how much virus is in your blood (known as the viral load). This information can help your healthcare provider choose the best treatments for you and monitor how well the treatments are working. Genotype Testing: There are seven major strains or genotypes of hepatitis C, named genotype 1–7. In the United States, genotype 1 is the most common strain, accounting for 60% or more of HCV cases. Genotype testing is a specific blood test that helps your healthcare provider determine the strain of HCV, which can help them tailor your treatments accordingly. Hepatitis C Core Antigen Test: This test measures the hepatitis C core antigen in your blood. It is not as accurate as the HCV RNA test and may fail to detect mild infections or those with low viral levels. But where HCV RNA is unavailable, doctors may use it along with antibody testing to detect HCV infections. Imaging Tests Your doctors may also ask you to do some imaging tests to assess your liver and determine if there’s any damage. Magnetic resonance elastography (MRE): This is a non-invasive test that combines magnetic resonance imaging (MRI) with an ultrasound to create a picture of your liver's health. This test can detect scarring of the liver (called fibrosis) due to chronic hepatitis C and other liver conditions. A common complication of long-term hepatitis C is cirrhosis, a severe stage of liver scarring. Transient elastography: This is another non-invasive test that uses ultrasound to assess the condition of your liver. A damaged liver will have some stiffness, which this test easily detects. Liver biopsy: A liver biopsy can be used to examine your liver condition more closely. During the procedure, a healthcare provider will administer local anesthesia and insert a thin needle into your abdomen to take a small sample of liver tissue. This liver sample is taken for further testing in a lab. Types of Hepatitis C Aside from the specific genotype of HCV, the type of hepatitis C can vary by how long the condition lasts. It’s separated into two groups: acute (short-term) and chronic (long-term). Acute infection: All cases of HCV begin as acute infections. You could have a brief infection and your body eventually clears the virus—either on its own or with treatment. Between 15-45% of people with HCV clear the virus within 6 months, meaning their case stays acute.Chronic infection: The remaining people with HCV (55-85%) will have the virus for longer than 6 months, making it chronic. Your immune system may not be able to recover from the virus on its own. However, a healthcare provider can prescribe antiviral treatments, which can prevent worsening symptoms and in some cases, help clear the virus. Chronic hepatitis C may become a lifelong condition. Research suggests that chronic HCV infections are more likely to get worse in people who also have: Alcohol use disorderCirrhosis, or severe scarring of the liver Hepatitis B, or liver inflammation that is caused by the hepatitis B virus (HBV) If not treated, chronic HCV infections can lead to permanent liver damage, seen in conditions like cirrhosis, liver cancer, and liver failure. What Is Hepatitis C? Screening for Related Conditions Several diseases of the digestive system—especially liver conditions—have similar symptoms as hepatitis C. Your healthcare provider will also want to check for any of the following conditions. Other liver conditions with similar symptoms to hepatitis C include: Other viral hepatitis, such as hepatitis A, B, D and EDrug-induced liver injury, or liver damage associated with drug use Alcoholic liver disease, or liver damage due to excess alcohol useAutoimmune hepatitis, caused by the immune system attacking liver tissueLiver cancer, of which hepatocellular carcinoma is a common type and complication of HCVLiver abscess, a pus-filled pocket due to infection or injury Your doctors can tell the difference between a hepatitis C infection and other liver diseases using hepatitis C screening and imaging tests. Conditions That May Coexist With Hepatitis C People with hepatitis C are more likely to have another disease or more than two diseases at the same time. After an HCV diagnosis, your healthcare provider may check if you have any other conditions that are commonly associated with hepatitis C. Some conditions include: Human immunodeficiency virus (HIV): About 4% of people with HCV may also have HIV. Having both HCV and HIV can increase your risk of severe liver damage. Your healthcare provider may order an HIV test to confirm your status. Depression: Research suggests that depression is common in people with HCV, especially those with a history of drug injections. If your doctor suspects you have depression, they may refer you to a mental health professional for further care. Diabetes: HCV is more common in people with type 2 diabetes, and HCV is associated with a greater risk of developing type 2 diabetes. Your doctor may ask you to do a fasting blood sugar test to check for raised blood sugar levels. Non-liver cancers: Besides liver cancer, researchers have also observed higher rates of other cancers in people with HCV. These include cancers of the lungs, pancreas, mouth, throat, and anus. A Quick Review Hepatitis C is a contagious viral disease that can cause permanent liver damage. To diagnose hepatitis C, your healthcare provider will need your medical history, a physical examination, and additional tests, such as blood tests. Imaging tests may be done to determine any liver damage. Your doctor may also order other tests to rule out other conditions with symptoms that are similar to those of hepatitis C. If you do have HCV, your healthcare provider can also check if you have other conditions commonly associated with hepatitis C, such as diabetes, HIV, depression, and certain cancers. Was this page helpful? Thanks for your feedback! Tell us why! Other Submit 13 Sources Health.com uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Gupta E, Bajpai M, Choudhary A. Hepatitis C virus: screening, diagnosis, and interpretation of laboratory assays. Asian J Transfus Sci. 2014;8(1):19-25. doi:10.4103/0973-6247.126683 Holtzman D, Asher AK, Schillie S. The changing epidemiology of Hepatitis C virus infection in the United States during the years 2010 to 2018. Am J Public Health. 2021;111(5):949-955. doi:10.2105/AJPH.2020.306149 Basit H, Tyagi I, Koirala J. Hepatitis C. In: StatPearls. StatPearls Publishing; 2022. Centers for Disease Prevention and Control. Hepatitis C questions and answers for health professionals. National Institute of Diabetes and Digestive and Kidney Diseases. Hepatitis C. U.S. Preventive Services Taskforce. Hepatitis C virus infection in adolescents and adults: screening. Freiman JM, Tran TM, Schumacher SG, et al. Hepatitis C core antigen testing for diagnosis of hepatitis C virus infection: a systematic review and meta-analysis. Ann Intern Med. 2016;165(5):345-355. doi:10.7326/M16-0065 Saludes V, González V, Planas R, Matas L, Ausina V, Martró E. Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging. World J Gastroenterol. 2014;20(13):3431-3442. doi:10.3748/wjg.v20.i13.3431 Cooper CL, Galanakis C, Donelle J. HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study. BMC Infect Dis. 2019; 19(712). doi: 10.1186/s12879-019-4315-6 Operskalski EA, Kovacs A. HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Curr HIV/AIDS Rep. 2011;8:12–22. doi:10.1007/s11904-010-0071-3 Hudson B, Walker AJ, Irving WL. Comorbidities and medications of patients with chronic hepatitis C under specialist care in the UK. J Med Virol. 2017;89(12):2158-2164. doi:10.1002/jmv.24848 Hammerstad SS, Grock SF, Lee HJ, Hasham A, Sundaram N, Tomer Y. Diabetes and hepatitis C: a two-way association. Front Endocrinol (Lausanne). 2015;6:134. doi:10.3389/fendo.2015.00134 Lam JO, Hurley LB, Lai JB. Cancer in people with and without hHepatitis C virus infection: comparison of risk before and after introduction of direct-acting antivirals. Cancer Epidemiol Biomarkers Prev. 2021;30(12):2188-2196. doi:10.1158/1055-9965.EPI-21-0742